Axonics

No compromises, just long-lasting therapy

With Axonics Sacral Neuromodulation, the choice between a rechargeable and recharge-free neurostimulator comes without compromising therapy longevity.

Why choose Axonics SNM?

Axonics has improved the patient and healthcare provider experience with sacral neuromodulation therapy, allowing patients to receive long-lasting relief without compromise.

Ease of charging

In a clinical study of patients who completed a 2-year follow-up:

• 91% rated the recharging experience as "easy"
• 94% found charging frequency and duration to be "acceptable"¹

Explore the ARTISAN-SNM study

Intuitive remote control

For both the F15 recharge-free and R20 rechargeable SNM systems:

• Designed to be pocket-sized and easy to use
• One-handed operation to connect to implantable neurostimulator (INS)
• Allows increase or decrease of stimulation

Patented interchangeable tined lead design

• Patented helical-tined lead designed to mitigate lead migration
• Visible and radiopaque markers for lead implantation
• Compatible with both F15 recharge-free and R20 rechargeable systems

MRI conditionally safe

Broad MRI access:

• 1.5 T and 3 T Full-Body Coil1.
• 5 T and 3 T Head Coil1.
• 5 T and 3 T Upper and Lower Extremity
• 1.5 T Full-Body Coil with Open Impedances (F15 only)
• 3 T Full-Body Coil with Lead Fragments (F15 only)

_{Under certain conditions. For more information  refer to Contact Us - Boston Scientific} 

SmartMRI™ technology:

• Designed to simplify the process for your patients to get an MRI
• Using the Remote Control, the patient or MRI Radiographer can easily confirm if a patient's Axonics System is ready to undergo a full-body MRI
• No additional office visit needed prior to MRI

Smart programming

A smart clinician programmer with a proprietary algorithm designed to simplify the programming process

• Proprietary algorithm that generates programming recommendations based on intra-operative responses and lead placement
• Designed to reduce the need to adjust therapy
• In a clinical study, 92% of patients were on one of their top two recommended programs after one year²

Compatible system components to streamline the therapy experience

• Clinician programmer to test stimulation during lead placement and program therapy settings
• External trial system offers basic and advanced trial options that are lightweight and discreet
• One tined lead compatible with both F15 and R20 systems, further improving the therapy experience and offering flexibility in clinical decision making

Two types of trials

_{2021, Neurourology Urodynamics, Pezzella et al.}

Two‐year outcomes of the ARTISAN‐SNM study for the treatment of urinary urgency incontinence using the Axonics rechargeable sacral neuromodulation system

The ARTISAN-SNM study is a 129-patient, single-arm, prospective, multicenter, pivotal clinical study approved under an FDA Investigational Device Exemption (IDE) to evaluate the safety and efficacy of Axonics Therapy for urinary dysfunction. The study was conducted in a total of 19 centers, 14 in the United States, and 5 in Western Europe with 2-year follow-up.

_{2020, Neurourology Urodynamics, Blok et al.}

Two‐year safety and efficacy outcomes for the treatment of overactive bladder using a long‐lived rechargeable sacral neuromodulation system

 The RELAX-OAB study was a 51-patient, post-market clinical follow-up study in Europe designed to test the safety and efficacy of Axonics Therapy for the treatment of overactive bladder. The study was conducted across 7 European centers. Patients in the RELAX-OAB study have completed long-term follow-up out to 2 years, showing sustained efficacy and safety of Axonics Sacral Neuromodulation Therapy.

Publication list

_{2018, Neurourology Urodynamics, Blok et al.}

Programming settings and recharge interval in a prospective study of a rechargeable Sacral Neuromodulation system for the treatment of overactive bladder

_{2018, Neurourology Urodynamics, Blok et al.}
Three-month clinical results with a rechargeable Sacral Neuromodulation system for the treatment of overactive bladder

_{2018, Neurourology Urodynamics, Elterman}
The novel Axonics rechargeable Sacral Neuromodulation System: Procedural and technical impressions from an initial North American experience

_{2018, Neurourology Urodynamics, Blok et al.}
A prospective, multicenter study of a novel, miniaturized rechargeable Sacral Neuromodulation system: 12-month results from the RELAX-OAB study

The system features of the Axonics F15 and the Axonics R20

_{*Stimulation settings at Frequency 14 Hz, Pulse Width 210 μs, impedance 1200 ohms} 

_{*Under certain conditions. For more information refer to Contact Us - Boston Scientific}